Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®Business Wire • 05/24/24
Court Dismisses Exact Sciences' ‘781 Patent Infringement Claim Against GeneoscopyBusiness Wire • 05/22/24
Court Ruling Enables Exact Sciences to Proceed with Lawsuit against GeneoscopyBusiness Wire • 05/21/24
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024InvestorPlace • 05/17/24
The National Institute for Health and Care Excellence (NICE) Recommends Use of Exact Sciences' Oncotype DX® Test to Help Guide Chemotherapy Decisions for Node-positive Breast Cancer PatientsBusiness Wire • 05/10/24
Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly LossesInvestors Business Daily • 05/08/24
Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024Business Wire • 05/07/24
Exact Sciences (EXAS) Stock Drops Despite Market Gains: Important Facts to NoteZacks Investment Research • 04/24/24
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior NotesBusiness Wire • 04/11/24
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024Business Wire • 04/08/24
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform TreatmentBusiness Wire • 04/04/24